In cancer therapy, the potential use of L. lactis NZ9000 strain concerned breast cancer, namely hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) [35]. This evidence concerns the gene MT-RNR2 and breast cancer.